COROLAS
COROLAS
Track global policy developments, regulatory frameworks, and compliance requirements shaping the future of AI in biotechnology.
Recent policy developments, guidance documents, and regulatory announcements
Loading policy news...
Key regulatory milestones and policy developments
Loading policy timeline...
Key regulatory bodies and their AI Γ Bio policies
AI/ML-based Software as Medical Device (SaMD) framework with pre-certification pathway. Risk-based approach to AI in drug development and diagnostics.
Learn more βEU AI Act establishes risk-based classification for AI systems. High-risk AI in healthcare requires conformity assessment and CE marking.
Learn more βChina's regulatory framework for AI medical devices, including deep learning-based software for medical imaging and diagnosis.
Learn more βUK's regulatory sandbox for AI medical devices, enabling innovative products to reach market faster with appropriate safeguards.
Learn more βGuidance on machine learning-enabled medical devices, emphasizing transparency and validation requirements.
Learn more βWorld Health Organization's ethical principles for AI in health, covering privacy, equity, and human oversight.
Learn more βKey metrics and trends in AI Γ Bio regulation
Get weekly updates on regulatory developments and compliance requirements.
No spam. Unsubscribe anytime.